HIV/AIDS Clinical Trials in San Antonio

Showing 501-504 of 504 trials

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

NCT00002048

To evaluate the safety and tolerance of chronic administration of Retrovir (AZT) in HIV-infected adult patients without clinical manifestations of disease. To assess the efficacy of AZT therapy in the treatment of HIV disease in these patients.

Lymphatic DiseaseHIV Infections

Glaxo Wellcome

La Jolla, California, United States • San Diego, California, United States • Washington D.C., District of Columbia, United States +19 more locations

COMPLETEDPhase 2190 miles

A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)

NCT00002170

The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are being treated for MAC.

Mycobacterium Avium-Intracellulare InfectionHIV Infections

Agouron Pharmaceuticals

San Diego, California, United States • Torrance, California, United States • Chicago, Illinois, United States +2 more locations

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)

HIV/AIDS Trials in Other Cities

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

Other Conditions in San Antonio